Form 4 holding
Chief Medical Officer
Poseida Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 111,485
- Estimated value
- $596,445
- Report date
- 01 Mar 2022
- Price
- $5.35
- Ownership
- Direct
Matthew A. Spear - Chief Medical Officer at Poseida Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- PSTX
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Matthew A. Spear since 14 Sep 2025
Reported holdings for Matthew A. Spear in Poseida Therapeutics, Inc.
Form 4 holding
Chief Medical Officer
Poseida Therapeutics, Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 72,568
- Estimated value
- Report date
- 01 Mar 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Matthew A. Spear in Poseida Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.